163
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Antiplatelet aggregation and endothelial protection of I4, a new synthetic anti-diabetes sulfonylurea compound

, &
Pages 342-348 | Received 17 Jan 2014, Accepted 03 Apr 2014, Published online: 15 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yizhu Chen, Wenlong Yang, Lingyu Guo, Xiaolin Wu, Tiantian Zhang, Junling Liu & Junfeng Zhang. (2017) Atractylodes lactone compounds inhibit platelet activation. Platelets 28:2, pages 194-202.
Read now

Articles from other publishers (4)

Angelo Cignarelli, Valentina Annamaria Genchi, Rossella D’Oria, Fiorella Giordano, Irene Caruso, Sebastio Perrini, Annalisa Natalicchio, Luigi Laviola & Francesco Giorgino. (2021) Role of Glucose-Lowering Medications in Erectile Dysfunction. Journal of Clinical Medicine 10:11, pages 2501.
Crossref
Lifen Qian, Lingman Ma, Guanzhong Wu, Qian Yu, Huisheng Lin, Qidi Ying, Dan Wen & Cong Gao. (2017) G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE −/− mice. Vascular Pharmacology 89, pages 49-57.
Crossref
Lingman Ma, Lifen Qian, Qidi Ying, Yan Zhang, Changlin Zhou & Guanzhong Wu. (2017) I 4 , a synthetic anti-diabetes agent, attenuates atherosclerosis through its lipid-lowering, anti-inflammatory and anti-apoptosis properties. Molecular and Cellular Endocrinology 440, pages 80-92.
Crossref
Alexander Berezin. (2016) Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 10:2, pages S176-S183.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.